Posts by: Margarida Azevedo, MSc

Margarida Azevedo, MSc

Margarida graduated with a BS in Health Sciences from the University of Lisbon and a MSc in Biotechnology from Instituto Superior Técnico (IST-UL). She worked as a molecular biologist research associate at a Cambridge UK-based biotech company that discovers and develops therapeutic, fully human monoclonal antibodies.

March 13, 2017March 13, 2017

Through the Pages, a Novel About Illness from Childhood Memories

Columns, Crohn's Corner - a column by Judy Walters

Editor’s note: Our IBD columnist, Judy Walters, will have a new book out Tuesday in which the central character has multiple sclerosis (MS). Here, she recalls how MS affected her ... Read more

March 10, 2017

Cellceutix Reports Positive Interim Results from Brilacidin Phase 2 Clinical Trial

News

Positive interim results were reported in the first two groups of ulcerative colitis patients being treated with Brilacidin (PMX-30063) in a dose-escalating Phase 2 clinical trial. Patients for a third and final group — ... Read more

March 9, 2017

Nominations Sought for Sherman Prize Honoring Bowel Disease Achievements

News

Nominations for the 2017 Sherman Prize, which will honor exceptional achievements in the fight against Crohn’s disease and ulcerative colitis (UC), will be accepted through April 30, according to the ... Read more

March 8, 2017

AXIM Starts Phase 2 IBS Trial of CanChew Plus Cannabinoid-based Gum

News

AXIM Biotechnologies has enrolled 40 patients with irritable bowel syndrome (IBS) and initiated a Phase 2 clinical trial evaluating the effectiveness of its CanChew Plus cannabinoid (CBD)-based chewing gum for ... Read more

March 8, 2017March 8, 2017

Does Living with Crohn’s Disease Mean We are Sick?

Columns, Crohn's Corner - a column by Judy Walters

I had an interesting discussion with a Crohn’s buddy recently. She said she doesn’t think of herself as sick, despite the fact that she’s had at least a half-dozen surgeries ... Read more

March 6, 2017March 6, 2017

Farm Use of Antibiotics Sparks Fears that Bacterial Resistance Could Spread IBD, Other Diseases

News

The growing use of antibiotics in conventional farming may lead to bacterial resistance to some lifesaving human medicines — making it harder to treat illnesses such as inflammatory bowel disease (IBD). The ... Read more

March 2, 2017

TopiVert Begins Phase 1 Study of Oral TOP1288 as Colitis Treatment

News

The first participant has been dosed in a Phase 1 American study evaluating TopiVert Pharma‘s oral version of TOP1288 as a treatment for ulcerative colitis (UC). The study will assess TOP1288’s ... Read more

March 2, 2017March 2, 2017

Medical Marijuana: From Laughable Suggestion to Legitimate Option

Columns, Crohn's Corner - a column by Judy Walters

So, I live in a state where medical marijuana is legal. I’d never thought much about it before, always assuming treatments would work for me, and also because, well, I’m ... Read more

March 1, 2017

Corticosteroids, High-Dose Pulmicort Both Effective Therapies for Mild-to-Moderate Crohn’s

News

Treatment with corticosteroids and high-dose Pulmicort (budesonide) are both effective induction therapies for patients with mild-to-moderate Crohn’s disease, though high-dose Asacol (mesalamine) also offers an effective alternative with fewer side effects. ... Read more

February 24, 2017

Colectomy Increases Risk of Gallstones in Patients with Ulcerative Colitis, Study Suggests

News

The risk of gallstones increases after patients with ulcerative colitis have undergone a colectomy, according to the results of a Danish study. The study, “Increased Risk of Gallstone Disease Following ... Read more